Literature DB >> 23602319

Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.

Nikolaos P Polyzos1, Scott M Nelson, Dominic Stoop, Milie Nwoye, Peter Humaidan, Ellen Anckaert, Paul Devroey, Herman Tournaye.   

Abstract

OBJECTIVE: To investigate whether the time interval between serum antimüllerian hormone (AMH) sampling and initiation of ovarian stimulation for in vitro fertilization-intracytoplasmic sperm injection (IVF-ICSI) may affect the predictive ability of the marker for low and excessive ovarian response.
DESIGN: Retrospective cohort study.
SETTING: University-based tertiary center. PATIENT(S): Five hundred and forty women with AMH values measured before their first IVF-ICSI cycle. INTERVENTION(S): Eligible patients treated with 150-225 IU recombinant follicle-stimulating hormone (FSH) in a gonadotropin-releasing hormone (GnRH) antagonist protocol. MAIN OUTCOME MEASURE(S): Predictive ability of AMH for low and excessive ovarian response in relation to the time interval between serum AMH sampling and initiation of ovarian stimulation for IVF-ICSI. RESULT(S): All patients had their AMH concentration measured up to 12 months before initiation of stimulation. The level of AMH demonstrated a statistically significant positive correlation with number of oocytes retrieved. The time interval between AMH measurement and initiation of stimulation had no influence on this correlation. The area under the receiver operator characteristic curve (ROC AUC) of AMH was high for both poor (0.72) and excessive response (0.80). The ROC regression analysis demonstrated that the time interval from sampling did not affect the performance of either poor response or excessive response prediction. CONCLUSION(S): A time interval up to 12 months between AMH serum sampling and initiation of ovarian stimulation does not appear to affect the correlation between AMH level and the number of oocytes retrieved and the predictive ability of AMH to identify women at risk of low or excessive ovarian response.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMH; AMH variability; OHSS; excessive responders; ovarian response; poor responder; stimulation; time interval

Mesh:

Substances:

Year:  2013        PMID: 23602319     DOI: 10.1016/j.fertnstert.2013.03.031

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Reliability of AMH and AFC measurements and their correlation: a large multicenter study.

Authors:  Philippe Arvis; Catherine Rongières; Olivier Pirrello; Philippe Lehert
Journal:  J Assist Reprod Genet       Date:  2022-03-03       Impact factor: 3.357

Review 2.  Management of poor responders in IVF: is there anything new?

Authors:  Filippo Ubaldi; Alberto Vaiarelli; Rosario D'Anna; Laura Rienzi
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

3.  Prediction of metaphase II oocytes according to different serum Anti-Müllerian hormone (AMH) levels in antagonist ICSI cycles.

Authors:  Joyce B da Silva; Tatiana R Panaino; Maria A Tamm; Paloma Lira; Patricia C F Arêas; Ana C A Mancebo; Marcelo M de Souza; Roberto A Antunes; Maria do Carmo B de Souza
Journal:  JBRA Assist Reprod       Date:  2016-12-01

4.  Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF.

Authors:  Jialyu Huang; Jiaying Lin; Hongyuan Gao; Yun Wang; Xiuxian Zhu; Xuefeng Lu; Bian Wang; Xinyan Fan; Renfei Cai; Yanping Kuang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-28       Impact factor: 5.555

5.  What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?

Authors:  Jure Knez; Borut Kovačič; Maruška Medved; Veljko Vlaisavljević
Journal:  Reprod Biol Endocrinol       Date:  2015-06-10       Impact factor: 5.211

Review 6.  Maximizing the clinical utility of antimüllerian hormone testing in women's health.

Authors:  Benjamin Leader; Valerie L Baker
Journal:  Curr Opin Obstet Gynecol       Date:  2014-08       Impact factor: 1.927

7.  The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation.

Authors:  Panagiotis Drakopoulos; Samuel Santos-Ribeiro; Ernesto Bosch; Juan Garcia-Velasco; Christophe Blockeel; Alessia Romito; Herman Tournaye; Nikolaos P Polyzos
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-23       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.